1. Home
  2. RCG vs PHGE Comparison

RCG vs PHGE Comparison

Compare RCG & PHGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCG
  • PHGE
  • Stock Information
  • Founded
  • RCG 1994
  • PHGE 2015
  • Country
  • RCG United States
  • PHGE Israel
  • Employees
  • RCG N/A
  • PHGE N/A
  • Industry
  • RCG Investment Managers
  • PHGE Biotechnology: Pharmaceutical Preparations
  • Sector
  • RCG Finance
  • PHGE Health Care
  • Exchange
  • RCG Nasdaq
  • PHGE Nasdaq
  • Market Cap
  • RCG 15.6M
  • PHGE 13.3M
  • IPO Year
  • RCG N/A
  • PHGE N/A
  • Fundamental
  • Price
  • RCG $2.87
  • PHGE $0.73
  • Analyst Decision
  • RCG
  • PHGE Strong Buy
  • Analyst Count
  • RCG 0
  • PHGE 2
  • Target Price
  • RCG N/A
  • PHGE $13.50
  • AVG Volume (30 Days)
  • RCG 5.9K
  • PHGE 110.1K
  • Earning Date
  • RCG 01-01-0001
  • PHGE 11-14-2024
  • Dividend Yield
  • RCG 0.98%
  • PHGE N/A
  • EPS Growth
  • RCG N/A
  • PHGE N/A
  • EPS
  • RCG N/A
  • PHGE N/A
  • Revenue
  • RCG N/A
  • PHGE N/A
  • Revenue This Year
  • RCG N/A
  • PHGE N/A
  • Revenue Next Year
  • RCG N/A
  • PHGE N/A
  • P/E Ratio
  • RCG N/A
  • PHGE N/A
  • Revenue Growth
  • RCG N/A
  • PHGE N/A
  • 52 Week Low
  • RCG $1.52
  • PHGE $0.48
  • 52 Week High
  • RCG $1.90
  • PHGE $8.55
  • Technical
  • Relative Strength Index (RSI)
  • RCG 65.66
  • PHGE 54.26
  • Support Level
  • RCG $2.32
  • PHGE $0.70
  • Resistance Level
  • RCG $2.58
  • PHGE $0.80
  • Average True Range (ATR)
  • RCG 0.12
  • PHGE 0.06
  • MACD
  • RCG 0.04
  • PHGE 0.00
  • Stochastic Oscillator
  • RCG 100.00
  • PHGE 41.18

About RCG RENN Fund Inc

RENN Fund Inc is active in the financial services domain. It is a closed-end management investment company formed to provide return through capital appreciation and income by a long-term, value-oriented investment process that invests in a wide variety of financial instruments, including but not limited to, common stocks, fixed-income securities including convertible and non-convertible debt securities or loans, distressed debt, warrants, and preferred stock, exchange-traded funds and exchange-traded notes, and other instruments. It invests in various industries, including communication services, surgical and medical instruments and apparatus, Oil and Gas, medical chemicals, botanical products, and others.

About PHGE BiomX Inc. COmmon Stock

BiomX Inc is a clinical-stage microbiome company based in Israel. The company is engaged in developing both natural and engineered phage cocktails designed to target and destroy harmful bacteria that affect the appearance of the skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease, colorectal cancer, and primary sclerosing cholangitis. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF.

Share on Social Networks: